Beginning September 10, breast imaging facilities will be required to notify patients about the density of their breasts, among other regulatory changes. 

The FDA ruled that this is a Class I recall due to the significant risks for patients. Customers are not required to return the devices, however. Inari Medical has provided updated warnings and recommendations that should be followed. 

Researchers combined data from three well-known clinical trials—NOTION, Evolut Low Risk and PARTNER 3—and evaluated thousands of low-risk patients who presented with severe aortic stenosis. 

Regulators emphasized that these devices should not be used due to significant safety risks. 

In total, 10,300 complaints were made against providers and air ambulance services. The rest were for surprise bills from insurance plans.

Maui Imaging says its product can produce images that are a "cross between ultrasound and CT" without the need for ionizing radiation. 

The NIH’s Office of Science Policy recently posted some essential new guidance for healthcare researchers. 

Kaiser Permanente AI exec Daniel Yang, MD: ‘With a focus on building trust, we use AI only when it advances our core mission of delivering high-quality, affordable healthcare services.’